NCT04541914View on ClinicalTrials.gov

Diagnostic Efficacy of Molecular Diagnostic Method for AMR in ABOiKT

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 19, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
ABO Blood Type Incompatible Kidney TransplantationAntibody-mediated Rejection
Interventions
DIAGNOSTIC_TEST

5-gene classification model

Peripheral blood marker-based molecular diagnostic method for AMR in ABOiKT

Trial Locations (1)

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT04541914 - Diagnostic Efficacy of Molecular Diagnostic Method for AMR in ABOiKT | Biotech Hunter | Biotech Hunter